Events Partner Content 14th Annual RNA Therapeutics Conference RNA / 8 - 9 February 2023 / London, UK
Partner Content Partner Content Official Invitation from Chair of RNA Therapeutics 2019 Conf... Invitation from Chair of RNA Therapeutics 2019
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
